Terms: = Uterine cancer AND ERBB2, c-erb B2, 2064, P04626, ENSG00000141736, c-erbB2, HER-2/neu, HER2, TKR1, NEU, NGL, HER-2 AND Clinical Outcome
27 results:
1. her2 Testing in Endometrial Serous Carcinoma: Time for Standardized Pathology Practice to Meet the clinical Demand.
Buza N
Arch Pathol Lab Med; 2021 Jun; 145(6):687-691. PubMed ID: 32649220
[TBL] [Abstract] [Full Text] [Related]
2. Chemoradiotherapy response prediction model by proteomic expressional profiling in patients with locally advanced cervical cancer.
Choi CH; Chung JY; Kang JH; Paik ES; Lee YY; Park W; Byeon SJ; Chung EJ; Kim BG; Hewitt SM; Bae DS
Gynecol Oncol; 2020 May; 157(2):437-443. PubMed ID: 32107047
[TBL] [Abstract] [Full Text] [Related]
3. Mismatch repair deficiency and aberrations in the Notch and Hedgehog pathways are of prognostic value in patients with endometrial cancer.
Polychronidou G; Kotoula V; Manousou K; Kostopoulos I; Karayannopoulou G; Vrettou E; Bobos M; Raptou G; Efstratiou I; Dionysopoulos D; Chatzopoulos K; Lakis S; Chrisafi S; Tsolakidis D; Papanikolaou A; Dombros N; Fountzilas G
PLoS One; 2018; 13(12):e0208221. PubMed ID: 30521558
[TBL] [Abstract] [Full Text] [Related]
4. Immunophenotype and human papillomavirus status of serous adenocarcinoma of the uterine cervix.
Togami S; Sasajima Y; Kasamatsu T; Oda-Otomo R; Okada S; Ishikawa M; Ikeda S; Kato T; Tsuda H
Pathol Oncol Res; 2015 Apr; 21(2):487-94. PubMed ID: 25370301
[TBL] [Abstract] [Full Text] [Related]
5. Clinicopathological and prognostic impact of human epidermal growth factor receptor type 2 (her2) and hormone receptor expression in uterine papillary serous carcinoma.
Togami S; Sasajima Y; Oi T; Ishikawa M; Onda T; Ikeda S; Kato T; Tsuda H; Kasamatsu T
Cancer Sci; 2012 May; 103(5):926-32. PubMed ID: 22329832
[TBL] [Abstract] [Full Text] [Related]
6. Immunohistochemical evaluation and lymph node metastasis in surgically staged endometrial carcinoma.
Pilka R; Marková I; Dusková M; Procházka M; Tozzi M; Kudela M
Eur J Gynaecol Oncol; 2010; 31(5):530-5. PubMed ID: 21061794
[TBL] [Abstract] [Full Text] [Related]
7. Molecule-targeted agents in endometrial cancer.
Delmonte A; Sessa C
Curr Opin Oncol; 2008 Sep; 20(5):554-9. PubMed ID: 19106660
[TBL] [Abstract] [Full Text] [Related]
8. Serous carcinoma of the uterus-determination of her-2/neu status using immunohistochemistry, chromogenic in situ hybridization, and quantitative polymerase chain reaction techniques: its significance and clinical correlation.
Singh P; Smith CL; Cheetham G; Dodd TJ; Davy ML
Int J Gynecol Cancer; 2008; 18(6):1344-51. PubMed ID: 18248390
[TBL] [Abstract] [Full Text] [Related]
9. Correlative expression of cyclooxygenase-1 (Cox-1) and human epidermal growth factor receptor type-2 (her-2) in endometrial cancer.
Sugimoto T; Koizumi T; Sudo T; Yamaguchi S; Kojima A; Kumagai S; Nishimura R
Kobe J Med Sci; 2007; 53(5):177-87. PubMed ID: 18204294
[TBL] [Abstract] [Full Text] [Related]
10. Novel molecular profiles of endometrial cancer-new light through old windows.
Doll A; Abal M; Rigau M; Monge M; Gonzalez M; Demajo S; Colás E; Llauradó M; Alazzouzi H; Planagumá J; Lohmann MA; Garcia J; Castellvi S; Ramon y Cajal J; Gil-Moreno A; Xercavins J; Alameda F; Reventós J
J Steroid Biochem Mol Biol; 2008 Feb; 108(3-5):221-9. PubMed ID: 18061438
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic value of her2 and progesterone receptor expression in endometrial carcinoma with positive peritoneal washing.
Benevolo M; Vocaturo A; Novelli F; Mariani L; Vocaturo G; Cianciulli AM; Marandino F; Perrone-Donnorso R; Giannarelli D; Natali PG; Mottolese M
Anticancer Res; 2007; 27(4C):2839-44. PubMed ID: 17695457
[TBL] [Abstract] [Full Text] [Related]
12. Epidermal growth factor receptor and human epidermal growth factor receptor 2 gene polymorphisms in endometrial cancer in a Japanese population.
Kitao K; Yoshida S; Kennedy S; Takemura N; Sugimoto M; Deguchi M; Ohara N; Maruo T
Reprod Sci; 2007 May; 14(4):349-57. PubMed ID: 17644807
[TBL] [Abstract] [Full Text] [Related]
13. Gene profiling in Pap-cell smears of high-risk human papillomavirus-positive squamous cervical carcinoma.
Manavi M; Hudelist G; Fink-Retter A; Gschwandtler-Kaulich D; Pischinger K; Czerwenka K
Gynecol Oncol; 2007 May; 105(2):418-26. PubMed ID: 17306351
[TBL] [Abstract] [Full Text] [Related]
14. uterine carcinosarcoma: immunohistochemical studies on tissue microarrays with focus on potential therapeutic targets.
Cimbaluk D; Rotmensch J; Scudiere J; Gown A; Bitterman P
Gynecol Oncol; 2007 Apr; 105(1):138-44. PubMed ID: 17175012
[TBL] [Abstract] [Full Text] [Related]
15. Glassy cell carcinoma of the cervix: cytologic features and expression of estrogen receptor, progesterone receptor and her2/neu protein.
Kuroda H; Toyozumi Y; Masuda T; Ougida T; Hanami K; Kyoko K; Tamaru J; Itoyama S
Acta Cytol; 2006; 50(4):418-22. PubMed ID: 16901007
[TBL] [Abstract] [Full Text] [Related]
16. Expression and amplification of her-2/neu oncogene in uterine carcinosarcomas: a marker for potential molecularly targeted treatment?
Raspollini MR; Susini T; Amunni G; Paglierani M; Castiglione F; Garbini F; Carriero C; Scarselli G; Taddei GL
Int J Gynecol Cancer; 2006; 16(1):416-22. PubMed ID: 16445668
[TBL] [Abstract] [Full Text] [Related]
17. Expression of cyclooxygenase-2 (COX-2), receptors for estrogen (ER), and progesterone (PR), p53, ki67, and neu protein in endometrial cancer.
Ferrandina G; Ranelletti FO; Gallotta V; Martinelli E; Zannoni GF; Gessi M; Scambia G
Gynecol Oncol; 2005 Sep; 98(3):383-9. PubMed ID: 15979129
[TBL] [Abstract] [Full Text] [Related]
18. cDNA array analysis of cytobrush-collected normal and malignant cervical epithelial cells: a feasibility study.
Hudelist G; Czerwenka K; Singer C; Pischinger K; Kubista E; Manavi M
Cancer Genet Cytogenet; 2005 Apr; 158(1):35-42. PubMed ID: 15771902
[TBL] [Abstract] [Full Text] [Related]
19. COX-2, c-KIT and her-2/neu expression in uterine carcinosarcomas: prognostic factors or potential markers for targeted therapies?
Raspollini MR; Susini T; Amunni G; Paglierani M; Taddei A; Marchionni M; Scarselli G; Taddei GL
Gynecol Oncol; 2005 Jan; 96(1):159-67. PubMed ID: 15589595
[TBL] [Abstract] [Full Text] [Related]
20. Relation between HPV-DNA and expression of p53, bcl-2, p21WAF-1, MIB-1, her-2/neu and DNA ploidy in early cervical carcinoma: correlation with clinical outcome.
Graflund M; Sorbe B; Sigurdardóttir S; Karlsson MG
Oncol Rep; 2004 Jul; 12(1):169-76. PubMed ID: 15201979
[TBL] [Abstract] [Full Text] [Related]
[Next]